genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Drug Discovery
Brain Cell Signaling Linked to Yo-Yo Effect of Dieting
Liquid Biopsies
Illumina, Icahn Spar over Board Indemnification for Grail Purchase
Cancer
Cancer Diagnosis and Treatment Could Be Affected by Circadian Rhythm
Antibodies
Blood Clotting Finding May Lead to New Approach to Improve Hemostasis
Gastrointestinal Disorders
Intracellular Sensor May Lead to Novel Skin and Intestinal Therapies
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
AgBio
Plants to Play Larger Role in Battle against COVID-19
Bioprocessing
Merck Biomanufacturing Optimization Sees Major Production Gains
Bioprocessing
Pharmaceutical Manufacturers Need to Stay Focused on Supply Chain Audit
Bioprocessing
Cell-Free Synthesis of Peptidomimetic Drugs by International Research Team
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
Therapeutics
Dermatologic Drugs
Dermatologic Drugs
Anti-Ulcerants
Antibacterials
Antibiotics
Anticoagulants
Antidiabetics
Antifungals
Antivirals
Autoimmune Disease Drugs
Biologics
Biosimilars
Cardiovascular Drugs
Cellular Therapeutics
Combination Therapies
Dermatologic Drugs
Enzyme Replacement Therapy
Generics
Hormone Replacement Therapy
Immuno-oncology
Immunotherapies
Lipid Regulators
Mental Health Drugs
Oncologics
Orphan Drugs
Pain
Protein Therapeutics
Psychoactive Drugs
Radiopharmaceuticals
Respiratory Drugs
Traditional Chinese Medications
Vaccines
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Gene Therapy
StockWatch: Seven Analysts Cut Price Target for Taysha on FDA Advice, Job Cuts
Drug Discovery
StockWatch: Investors Unfazed by Biogen CEO Search, Aduhelm Cutbacks
Dermatologic Drugs
Eczema Risk Higher If Gene Variants Lower Skin Barrier
Dermatologic Drugs
Soothing Eczema by Riling Natural Killer Cells
Dermatologic Drugs
MorphoSys, Galapagos Halt Development of Atopic Dermatitis Candidate Licensed to Novartis
Dermatologic Drugs
BMS Selling Celgene’s Otezla to Address FTC “Concerns” on $74B Deal
Dermatologic Drugs
Aslan Acquires Full Rights to CSL Atopic Dermatitis Candidate for $780M+
Dermatologic Drugs
Leo Pharma Expands Translational Medicine Focus with New Executives, Partnerships
Dermatologic Drugs
Leo Pharma to Acquire Bayer Prescription Dermatology Portfolio
Dermatologic Drugs
Novartis Licenses MorphoSys/Galapagos Atopic Dermatitis Candidate MOR106 for $1.1B+
Dermatologic Drugs
GSK Sells Psoriasis/Dermatitis Candidate Tapinarof to Dermavant
Dermatologic Drugs
MorphoSys to Advance Pipeline, Platform Through Up-to-$150M U.S. IPO
Dermatologic Drugs
Biodegradable Bandages Designed to Accelerate Regeneration of Damaged Tissues
Dermatologic Drugs
Menlo Therapeutics Files for Up-to-$97.75M IPO
Dermatologic Drugs
Fire Ant Venom Toxin Analogs Improve Psoriasis in Mice
1
2
Page 1 of 2
Scroll Up